{"created":"2023-05-15T16:37:27.165266+00:00","id":10838,"links":{},"metadata":{"_buckets":{"deposit":"1ea1d172-3e18-413e-a5d2-a7188f81b0d8"},"_deposit":{"created_by":2,"id":"10838","owners":[2],"pid":{"revision_id":0,"type":"depid","value":"10838"},"status":"published"},"_oai":{"id":"oai:nagasaki-u.repo.nii.ac.jp:00010838","sets":["8:9"]},"author_link":["42546","42547","42544","42542","42543","42545","42548"],"item_2_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2012-05-15","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"10","bibliographicPageEnd":"1243","bibliographicPageStart":"1239","bibliographicVolumeNumber":"51","bibliographic_titles":[{"bibliographic_title":"Internal Medicine"}]}]},"item_2_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"A 52-year-old woman was diagnosed with Blau syndrome and rheumatoid arthritis and was treated with prednisolone and methotrexate. Joint pain and skin ulcers were poorly controlled; therefore, mizoribine (MZ; 150 mg/day) was administered once daily from March 2011. In early July 2011, the patient was hospitalized because of acute kidney injury (AKI) and acute pancreatitis. We reasoned that AKI resulted from hyperuricemia during MZ administration because serum concentrations of uric acid (31.6 mg/dL) and MZ (trough level, 5.14 μg/mL) were markedly elevated on admission. MZ should be administered with caution because of the risk of marked hyperuricemia leading to AKI.","subitem_description_type":"Abstract"}]},"item_2_description_63":{"attribute_name":"引用","attribute_value_mlt":[{"subitem_description":"Internal Medicine, 51(10), pp.1239-1243; 2012","subitem_description_type":"Other"}]},"item_2_publisher_33":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"日本内科学会"}]},"item_2_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.2169/internalmedicine.51.7230","subitem_relation_type_select":"DOI"}}]},"item_2_rights_13":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"© 2012 The Japanese Society of Internal Medicine."}]},"item_2_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"09182918","subitem_source_identifier_type":"ISSN"}]},"item_2_text_62":{"attribute_name":"出版者別言語","attribute_value_mlt":[{"subitem_text_value":"The Japanese Society of Internal Medicine"}]},"item_2_version_type_16":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Nishino, Tomoya"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Shinzato, Takeaki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Ohta, Yuuki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Yamashita, Hiroshi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Obata, Yoko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Shinzato, Ken"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Kohno, Shigeru"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-12-22"}],"displaytype":"detail","filename":"IntMed51_1239.pdf","filesize":[{"value":"163.3 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"IntMed51_1239.pdf","url":"https://nagasaki-u.repo.nii.ac.jp/record/10838/files/IntMed51_1239.pdf"},"version_id":"492fa0ee-e4cb-4e2f-a3b2-636f87973ad1"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Acute kidney injury","subitem_subject_scheme":"Other"},{"subitem_subject":"Acute pancreatitis","subitem_subject_scheme":"Other"},{"subitem_subject":"Hyperuricemia","subitem_subject_scheme":"Other"},{"subitem_subject":"Mizoribine","subitem_subject_scheme":"Other"},{"subitem_subject":"Uric acid nephropathy","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"A Case of Acute Kidney Injury with Marked Hyperuricemia During Mizoribine Administration","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"A Case of Acute Kidney Injury with Marked Hyperuricemia During Mizoribine Administration"}]},"item_type_id":"2","owner":"2","path":["9"],"pubdate":{"attribute_name":"公開日","attribute_value":"2012-10-09"},"publish_date":"2012-10-09","publish_status":"0","recid":"10838","relation_version_is_last":true,"title":["A Case of Acute Kidney Injury with Marked Hyperuricemia During Mizoribine Administration"],"weko_creator_id":"2","weko_shared_id":-1},"updated":"2023-05-16T01:23:48.125633+00:00"}